アリル炭化水素受容体リガンドは,前腫瘍性T細胞の偏化による臓がんの発症と進行を誘導する
Brian D Griffith1, Padma Kadiyala2, Jake McGue2
1University of Michigan-Ann Arbor, United States.
Cancer discovery
|September 4, 2025
まとめ
タバコの煙は免疫細胞の アリル炭水化物受容体 (AhR) を活性化し 臓がんの進行を促します 喫煙者やPDAC患者で観察されたこの免疫機能の異常は,喫煙と臓腺がんを結びつけるメカニズムを強調しています.
科学分野:
- 免疫学
- 腫瘍学
- 毒理学について
背景:
- 喫煙は臓腺がん (PDAC) の危険因子として知られています.
- 喫煙がPDACの発達に影響する具体的なメカニズムは,ほとんど不明です.
- アリル炭化水素受容体リガンド (AhRLs) は,タバコの煙に存在し,AhR経路を活性化することができます.
研究 の 目的:
- PDACの腫瘍発生と進行におけるタバコの煙成分によるAhR活性化の役割を調査する.
- 喫煙によって引き起こされるPDACの増殖の原因となる免疫メカニズムを解明する.
- 喫煙歴のあるヒトとPDAC患者のAhR活性化と免疫細胞の変化を相関させる.
主な方法:
- TCDDのようなAhRリガンドの効果を研究するためにPDACのマウスモデルを使用した.
- CD4+ T細胞 (TH22,Treg) とCD8+ T細胞を含む免疫細胞群をAhR活性化反応として分析した.
- 臓器提供者およびPDAC患者からのヒト臓組織を検査し,喫煙状況に関連してAhR活性化およびTreg蓄積を評価した.
主要な成果:
- TCDDによるAhRの活性化により,マウスの胰腺不形成症とPDACの進行が促進された.
- CD4+ T細胞におけるAhRの活性化により,TH22細胞の極化とTregの蓄積が起こり,CD8+ T細胞の反応が抑制された.
- 喫煙者はAhRの活性化が増加し,喫煙者のPDAC腫瘍は非喫煙者に比べてTregの蓄積が増加した.
結論:
- 喫煙中のAhRリガンドは,特にTH22およびTreg細胞誘導により,免疫反応の調節を妨げ,PDACの腫瘍形成と進行を促進する.
- マウスモデルでの発見は,ヒトの臓組織での観察によって裏付けられ,喫煙とPDACの特定の免疫変化を関連付けました.
- この研究では 免疫調節による喫煙と 臓がんの発症のメカニズム的な関連が示されています
関連する概念動画
03:03mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
01:25Mutagenicity and Carcinogenicity
1.4K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.4K
02:38Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
01:33Cancer-Critical Genes I: Proto-oncogenes
9.1K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.1K